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TRANSCRIPTASE-POLYMERASE CHAIN REACTION USING
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JURAND JANUS, ICHIRO KURANE, ANDFRANCIS A. ENNIS
Division of infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts;
Department of Virology. U.S. Army Medical Component, Armed Forces Research institute of Medical Sciences,
Bangkok, Thailand; Department of Infectious Disease, Bangkok Children â€˜sHospital, Bangkok, Thailand
Abstract. A reverse transcriptaseâ€”polymerase chain reaction (RT-PCR) method was developed as a rapid diag
nostic test of dengue viremia. To detect dengue viruses in serum or plasma specimens, a pair of universal primers
was designed for use in the RT-PCR. Using these primers, the 3'-noncoding region of dengue virus types 1, 2, 3,
and 4 could be amplified, but not those of other flaviviruses, such as West Nile virus, Japanese encephalitis virus,
and yellow fever virus, or the alphavirus Sindbis virus. The sensitivity of the RT-PCR assay was similar to that of a
quantitative fluorescent focus assay of dengue viruses in cell culture. Combining a silica method for RNA isolation
and RT-PCR dengue virus could be detected in a 6-hr assay. In a preliminary study using this method, we detected
dengue virus in 38 of 39 plasma specimens from which dengue virus had been isolated by mosquito inoculation. We
then applied this method for detecting dengue viremia to 117 plasma samples from 62 children with acute febrile
illnesses in a dengue-endemic area. We detected dengue viremia in 19 of 20 samples obtained on the day of presen
tation, which had been confirmed as acute dengue infection by mosquito inoculation and antibody responses. The
overall sensitivity of this method was 91.4% (32 of 35; 95% confidence interval [CII = 82.2â€”100%). The results
from testing plasma samples from febrile nondengue patients showed a specificity of 95.4% (42 of 44; 95% CI =
89.3â€”100%).
Dengue virus infections can cause two forms of disease;
dengue fever and dengue hemorrhagic fever. Dengue fever
is a self-limited, febrile disease while dengue hemorrhagic
fever can lead to life-threatening complications. Currently,
the laboratory diagnosis of dengue infection depends upon
isolation of dengue virus using mosquito cell cultures' or
inoculation of mosquitoes;2 or detection of anti-dengue an
tibody by 1gM or IgG ELISA3 and/or hemagglutination in
hibition assays.4 Virus isolation, which is specific and rela
tively sensitive early in infection, is tedious and time-con
suming. Serologic tests, while simple to perform, generally
require paired serum samples.3
The polymerase chain reaction (PCR) has the potential for
sensitive, specific, and rapid detection of minute quantities
of certain genetic material in clinical specimens, thus pro
viding an attractive approach for the rapid identification of
dengue infection. Several methods of reverse transcriptase
(RT)-PCR using different pairs of primers for dengue viruses
and different approaches for the detection of amplification
products have been previously reported.514 However, most
of the published methods require more than 24 hr for anal
ysis. Rapid RT-PCR methods for detection of dengue vire
mia have been rt710' II 13but they have not been val
idated for detecting all four dengue serotypes in clinical
specimens.
In this report we describe a rapid RT-PCR procedure us
ing primers that amplify the 3'-noncoding region of dengue
virus types 1, 2, 3, and 4, but not those of other flaviviruses,
such as West Nile virus, Japanese encephalitis virus, and
yellow fever virus, or the alphavirus Sindbis virus. Combin
ing a silica method for RNA isolation and the RT-PCR, we
could detect dengue virus in serum or plasma within 6 hr.
The data presented in this paper demonstrate that this assay
is sufficiently rapid and sensitive to allow early diagnosis of
dengue virus infections.
MATERIALS AND METHODS
Plasma samples. Blood samples were obtained from chil
dren enrolled in a prospective study of dengue infections at
the Children's Hospital, Bangkok, Thailand, and the Kam
phaeng Phet Provincial Hospital, Kamphaeng Phet, Thai
land, in 1994 (Kalayanarooj S and others, unpublished data).
Children with fever of 72 hr or less in duration and facial
flushing without obvious cause were eligible to participate
in this study. Written consent was obtained from the sub
ject's parents or guardians. The study protocol was approved
by Institutional Review Boards established by the Ministry
of Public Health, Thailand, the Surgeon Generals's Office of
the Department of the Army, and the University of Massa
chusetts Medical Center. Blood was drawn daily until one
day after defervescence or up to five days, and then at con
valescence (8â€”10days after enrollment). Blood was collect
ed into EDTA-containing tubes; plasma was separated and
stored at -70Â°C until the RT-PCR was performed. Each
specimen collected had dengue 1gM and IgG ELISA and
hemagglutination inhibition assays performed. Dengue virus
isolation was attempted by mosquito inoculation2 for the first
three consecutive days or until virus isolation was negative
on subsequent days tested (Vaughn DW and others, unpub
lished data). A child was diagnosed as having acute dengue
infection when the serologic test results were positive, and/or
dengue virus could be isolated. Control specimens used in
this study were from children with febrile illness but no cv
idence of acute dengue infection by serologic tests with ap
propriately timed specimens and when mosquito inoculation
test results were negative for dengue virus in their plasma.
Extraction of RNA. The RNA was extracted from human
serum spiked with dengue virus or human plasma from feb
rile patients by a modification of the silica method that was
first described by Boom and others,'5 and later applied to
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FIGURE 1. A, sequence alignment of primers ALD-l, ALD-lb, and ALD-2 with dengue (DEN) virus conserved regions. The nucleotides
are numbered according to the dengue- 1 genome described by Fu and@ B, ethidium bromideâ€”stainedagarose gels for analyzing the
sensitivity of the reverse transcriptaseâ€”polymerase chain reaction (RT-PCR) for dengue virus types 1 to 4 as described in the Materials and
Methods. Lane C, normal human serum used as a negative control; lane M, molecular weight marker (@Xl74 replicative form DNA digested
with Hae III). The location of the expected PCR products are shown (229 basepairs [bpj, 233 bp, 227 bp, and 241 bp for dengue virus type
1, 2, 3, and 4, respectively). FRi = fluorescent focus units; FFU/Rx = fluorescent focus unit per reaction.
isolation of dengue virus RN713 Briefly, 20 p.1 of sample
was vortexed for 5 sec with 180 pA of lysing buffer (4 M
guanidine isothiocyanate, 40 mM Ths-HC1 pH 6.4, 17 mM
EDTA, pH 8.0, 1% Triton X-100) and 8 p.1 of acid-treated
size fractionated silica particles (Sigma Chemicals, St. Louis,
MO), then allowed to stand at room temperature for 10 mm,
mixed again, and pelleted by centrifugation at 13,000 X g
for 15 sec. The silica pellet was washed twice in 200 p.1 of
washing buffer (50% ethanol, 10 mM Tris-HCI, pH 7.4, 1
mM EDTA, and 50 mM NaCl), and finally rinsed in 100 p.1
of diethyl pyrocarbonateâ€”treated water. The pellet was re
suspended in 15 p.1 of water containing 2.5 U of RNase
inhibitor (Pharmacia, Piscataway, NJ) and incubated at 56Â°C
for 7 miii. After centrifugation at 13,000 X g for 2 mm, 14
p.1 of the RNA sample was collected.
Primers. We analyzed the sequence data on dengue vi
ruses in the Genbank database (National Center for Biotech
nology Information, Bethesda, MD). We chose to analyze
the noncoding region that is thought to function in regulation
of virus replication and that we expected to be well con
served among dengue viruses. We compared the sequences
of dengue virus type 1 Singapore 5275/90 strai&6 (Genbank
accession M875 12), dengue virus type 2 New Guinea C
strain'7 (M29095 M19727), dengue virus type 2 Jamaica
strain'8 (M20558), dengue virus type 2 S 1 vaccine strain'9
(M19197), dengue virus type 3 H87 strain20 (M93130), den
gue virus type 4 Caribbean 814669 strain2' (M14931
M17255), and the related viruses Japanese encephalitis vi
rus22 (Ml8370, MS5506, D90195), yellow fever virus23
(1(02749), and Kunjin virus24 (D00246). We found a region
corresponding to nucleotides 10,406 to 10,423 of dengue- 1
that is highly conserved in all four serotypes of demgue virus.
Within this region, only two base changes in dengue-2 were
found. In the other flaviviruses checked, with maximal align
ment, a difference of at least five bases was found. For the
sense primer we chose a mixture of the sequence homolo
gous to dengue 1, 3, and 4 (ALD-1: 5'-AAA CCG TGC
TGC D'G TAG-3') and the sequence homologous to den
gue-2 (ALD- lb: 5'-AAA CTG TGC AGC CTG TAG-3').
For the antisense primer, we selected an oligonucleotide that
is complementary to nucleotides 10,617 to 10,634 of den
gue-1 (ALD-2: 5'-TCT CTC CCA GCG TCA ATA-3'). This
sequence is also conserved in demgue-3. In dengue-2 and
dengue-4, there is a single base difference (Figure 1A). In
Japanese encephalitis virus and yellow fever virus, there are
four and three base mismatches, respectively. Despite the
highly conserved nature of our primers, the regions between
the primers are quite variable. The sequence identity of the
PCR products among the four serotypes of dengue virus
ranges between 77% and 90%. The expected sizes of the
PCR products are 229 basepairs (bp), 233 bp, 227 bp, and
241 bp for dengue virus types 1, 2, 3, and 4, respectively.
Reverse traflscriDtaseâ€”DOlVmeraSe chain reaction. The
method we used consists of reverse transcription using the
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downstream primer ALD-2, heat inactivation of the reverse
transcriptase, and PCR incorporating the upstream primers
ALD-l and ALD-ib. Fourteen microliters of isolated RNA
was added to 6 p.1of RT mixture solution containing 50 mM
KC1, 10 mM Tris-HC1 (pH 9.0 at 25Â°C),0.1% Triton X-l00,
1.0 mM MgC12, 25 pmol of downstream primer ALD-2, 0.2
mM of each dNTP, 2.0 U of avian myeloblastosis virus
(AMV) reverse tramscriptase (Promega, Madison, WI), and
4.0 U of RNase inhibitor (Pharmacia). Reverse transcription
was carried out at 42Â°Cfor 30 miii, followed by inactivation
of the reverse transcriptase at 95Â°C for 5 mm. Thirty mi
croliters of the PCR mixture was then added to the reaction
mixture. The PCR mixture contains 50 mM KC1, 10 mM
Tris-HC1 (pH 9.0 at 25Â°C),0.1% Triton X-lOO, 1.0 mM
MgCl2, 25 pmol of each upstream primer ALD- 1 and ALD
lb. 0.2 mM of each dNTP, and 1.25 U of Tth DNA poly
merase (Promega). The reaction was carried out at 92Â°Cfor
1 mm, 53Â°Cfor 1 mm, and 72Â°Cfor 1 mm for 10 cycles,
and continued at 92Â°Cfor 30 sec, 55Â°Cfor 30 5cc, and 72Â°C
for 30 sec for 30 cycles, followed by incubation at 72Â°Cfor
5 mu. Fifteen microliters of sample was subjected to 2.2%
agarose gel electrophoresis and the gel was then stained with
ethidium bromide.
Viruses. To optimize the RT-PCR technique and to ana
lyze its sensitivity, we used reference virus strains: dengue
virus type 1 Hawaii strain, dengue virus type 2 New Guinea
C strain, dengue virus type 3 CH53489 strain, and dengue
virus type 4 814669 strain.
Fluorescent focus assay Virus stocks were titered by flu
oresdent focus assay in CV-! cells.25 Briefly, cells were in
fected with serially diluted virus in eight-chamber slides. Af
ter incubation for 20 hr at 37Â°C,slides were fixed and stained
using an indirect fluorescent antibody technique using mouse
anti-dengue hyperimmune ascitic fluid and fluorescein iso
thiocyanate (FITC)â€”conjugated sheep anti-mouse IgG, and
infected cells were counted. Our unpublished data showed
that the sensitivity of this method is comparable to a plaque
assay in CV-l cells.
Mosquito inoculation assay. Virus culture was per
formed by the method described by Rosen and Gubler.2 Brief
ly, undiluted plasma was inoculated into adult Toxorhynchi
tes splendens (0.34 p.1per mosquito, 20 mosquitoes per spec
imen). Mosquitoes were incubated at 30Â°Cfor 12â€”14days.
Infected mosquitoes were detected by fluorescent antibody
(FA) staining of head squashes using polyvalent anti-dengue
mouse ascitic fluid and anti-mouse IgG-FITC. All mosquito
bodies from specimens that yielded at least one FA-positive
head were triturated in RPM! 1640 medium plus 10% fetal
calf serum; triturates were passaged one or more times in
25-cm2 tissue culture flasks of C6/36 cells for seven days.
Culture supernatants were assayed with virus-specific mono
clonal antibodies [flavivirus group (4G2), dengue complex
(2H2), dengue-1 (lFl), dengue-2 (3H5), dengue-3 (lOClO),
dengue-4 (lHlO), Japanese encephalitis virus (J93)] in an
antigen-capture ELISA.26
RESULTS
Sensitivity and specificity of the RT-PCR. The sensitiv
ity of the RT-PCR was determined by comparison with the
immunofluorescent focus assay. The RT-PCR was applied to
normal human serum (human AB serum; Advanced Bio
technologies Inc., Columbia, MA) spiked with 10-fold serial
dilutions of reference virus stocks. The RNA was isolated
from each dilution and was subjected to RT-PCR as de
scribed in the Materials and Methods. Water used to elute
the RNA or human AB serum was used as a negative con
trol. As seen in Figure lB. the sensitivity of the RT-PCR in
detecting virus RNA in human serum is at least 2 fluorescent
focus units (FFU)120-p.l sample for dengue-1,, 3, and, 4 vi
ruses, and 20 FFU/20-pJ sample for dengue-2 virus. Other
than the bands of expected size, there was a minor faint band
that migrated faster than the major band in samples contain
ing dengue-l, dengue-3, and dengue-4. This minor band de
creased in intensity in parallel to the intensity of the major
band in serial dilutions of virus as well as by increasing the
annealing temperature, and was not present in negative se
rum controls. We speculate that this band might result from
the secondary structure of the 3'-noncoding region products.
This method also gave positive results with other labora
tory strains of dengue viruses tested, including dengue virus
type- 1 Mochizuki strain, dengue virus type-2 strains Thai
257 and Ml 1355, dengue virus type 3 strains Sri Lanka-904
and Sri Lanka-969, and dengue virus type 4 strains H241
and Thai-286. Results were negative for West Nile virus,
yellow fever virus, Japanese encephalitis virus, and Sindbis
virus.
Preliminary study of plasma specimens from children
with acute dengue infection. In a preliminary study to con
firm whether our results with serum spiked with dengue vi
rus also applied to clinical samples, we applied our method
to 39 plasma samples from children with dengue fever or
dengue hemorrhagic fever. Dengue virus had previously
been isolated from these samples by mosquito inoculation.
We tested six samples containing dengue-1, 10 samples with
dengue-2, six samples with dengue-3, and 16 samples with
dengue-4. All the samples had been obtained on the day of
clinic presentation, no more than 72 hr after the onset of
fever, and from zero to five days before defervescence. Re
sults of PCR analysis are shown in Table 1 by day relative
to defervescence. Thirty eight of the 39 samples were pos
itive by RT-PCR. The one negative specimen was obtained
from a dengue-2â€”virus infected patient on the last day of
fever. Two samples from healthy persons and one sample
from a patient with hepatitis C gave negative results.
Comparison of RT-PCR and mosquito inoculation for
detection of viremia. To further study the sensitivity and
specificity of this RT-PCR method in comparison with the
mosquito inoculation method, we tested plasma specimens
from 20 subjects known to have dengue viremia, comprising
five subjects infected with each of the four serotypes. For
each subject, we studied the plasma sample obtained at en
rollment (study day 1), the last daily plasma sample that
yielded dengue virus by mosquito inoculation (last mosquito
inoculation positive), the plasma sample from the next daily
bleed (first mosquito inoculation negative), and the conva
lescent sample (follow-up). In most cases mosquito inocu
lation was not performed on follow-up plasma specimens
because a previous blood specimen was negative for viremia
and we assumed that later samples would have been negative
if tested. We tested a total of 73 samples from these 20
patients; in some cases the last mosquito inoculation positive
Dengue serotypeTotalDay
that samples were obtained relative todefervescenceâ€”5â€”4â€”3â€”2â€”
I0UnknowntDengue-l
Dengue-2
Dengue-3
Dengue-4
Total6/6
10/11
6/6
16/16
38/39â€”
1/1
â€”
â€”
1/12/2
2/2
â€”
â€”
4/41/1
3/3
2/2
4/4
10/102/2
2/2
2/2
8/8
14/141/1
2/2
1/1
4/4
8/8â€”
0/1
â€”
â€”
0/1â€”
1/1
â€”
1/1
Dengue5NondenguetVirus
isolation
positiveVirus
isolation
negativeVirus
isolation
negativeRT-PCR
positive
RT-PCR negative
Total32
3
356@
32
382@
42
44
Sample (PCR
Virus Day I Last MI+'+/no.
tested)1st
MIâ€”t Follow-up
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TABLE 1
Comparison of reverse transcriptaseâ€”polymerase chain reaction with mosquito inoculation for dengue virus detection in plasma specimens
(preliminary study)
S The day when the body temperature decreased and remained below 38'C is defined as day zero.
t Subject withdrawn from the study before defervescence.
was the same as the study day 1 sample or no blood sample
was obtained on the day after the last mosquito inoculation
positive sample. As a control group, we selected at random
plasma samples obtained at enrollment from 44 study sub
jects who had no serologic evidence of dengue infection and
whose blood samples were negative for dengue viremia by
mosquito inoculation. Coded specimens were tested by
RT-PCR.
Of the 73 samples obtained from patients with dengue
infection, 35 samples were positive by mosquito inoculation,
while RT-PCR detected dengue viremia in 38 samples. Thir
ty-two of the RT-PCR-positive samples were also positive
by mosquito inoculation, and six samples were mosquito in
oculation negative or not done. Three of 35 samples positive
by mosquito inoculation were negative by RT-PCR. Among
44 samples from the febrile nondengue control group, two
samples were positive by RT-PCR (Table 2).
Tables 3 and 4 show RT-PCR results for samples from
patients with dengue viremia with reference to the time of
sample collection. Of 20 samples obtained on the day of
presentation, we detected dengue virus in 19 samples by
RT-PCR. The one negative sample was obtained from a den
gue-2-infected patient two days before defervescence. Of the
20 samples obtained on the last day that yielded dengue
virus by mosquito inoculation, from three days before to one
day after defervescence, we detected dengue viremia by
RT-PCR in 17 samples, but failed to detect dengue RNA in
one sample each of dengue-2, dengue-3, and dengue-4. Of
the 18 first mosquito inoculationâ€”negative samples, obtained
between two days before and one day after defervescence,
we detected dengue virus in two samples that were positive
in mosquitoes for dengue-3 and in one sample positive for
TABLE 2
Comparison of reverse transcriptaseâ€”polymerase chain reaction (RT
PCR) with mosquito inoculation for detection of dengue viremia
during acute febrile illness
dengue-4. Of 19 follow-up samples we detected dengue vi
remia by RT-PCR in one sample from a dengue-1-infected
patient obtained four days after defervescence, and in two
dengue-2 samples that were obtained five and seven days
after defervescence. Results from these samples showed
weak bands. Mosquito inoculation assays had not been per
formed on these specimens.
We repeated RT-PCR on samples that gave discrepant re
sults between RT-PCR and mosquito inoculation. Two fol
low-up samples (both dengue-2), two first mosquito inocu
lationâ€”negative samples (both dengue-3), one last mosquito
inoculationâ€”positive sample, and two samples from the con
trol group, which were positive by RT-PCR on the first test,
were negative on repeat testing. One dengue-3 sample that
was negative in the first RT-PCR and positive for mosquito
inoculation gave a positive result on the second test.
DISCUSSION
We describe an alternative method for a sensitive, rapid,
simple and economical RT-PCR procedure for the diagnosis
of dengue virus infection. There are several reports describ
ing RT-PCR for the detection of dengue virus using different
approaches for the amplification of viral RNA and the de
tection of the PCR product. The objectives of several of
these reports were to detect and determine the serotype of
virus strains that had been isolated in mosquitoes or tissue
culture. For this purpose, RT-PCR followed by hybridiza
12 or nested PCR9 gave good results. Although the sen
sitivity was good, these procedures still required consider
able time and labor for use in patient management. Morita
and &â€˜ I proposed a rapid and simple method using
NP-40 and type-specific primers in which RNA isolation,
TABLE 3
Reverse transcriptase-polymerase chain reaction (RT-PCR) positivity
of plasma from patients infected with dengue virus
Dengue-l 5/5 4/5 0/5 1/5
Dengue-2 4/5 4/51: 0/4 2/5
Dengue-3 5/5 4/51: 2/4 0/4
Dengue-4 5/5 5/5:1: 1/5 0/5
Total 19/20 17/20 3/18 3/19
a The last daily plasma sample that yielded dengue virus by mosquito inoculation (MI).
t The first daily plasmasamplethat was negative for denguevirus by mosquito inocu
lation.
@ One of these samples was a first day sample.
* Acute febrile dengue virus infection confirmed by mosquito inoculation and serologic
tests.
t Acute febrile illnesswithout evidenceof acutedengueinfection by mosquitoinoculation
and complete serologic testing.
@ Five of these showed weak bands and were negative on repeat testing.
Â§Both showed weak bands and were negative on repeat testing.
TotalDengue-lDengue-2Dengue-3Dengue-4Fever
daytMI+PCR+MI+PCR+MI+PCR+MI+PCR+MI+PCR+â€”7
to â€”4 2/2
â€”3to â€”1 25/30
0 5/14
1 to 3 1/7
4 to 8 0/17
Unknown 2/3
Total 35/732/2
24/30
4/14
2/7
3/17
3/3
38/732/2
6/7
2/5
0/2
0/4
â€”
10/202/2
6fl
1/5
0/2
1/4
â€”
10/20â€”
7/8
1/3
1/2
0/5
â€”
9/18â€”
6/8
1/3
1/2
2/5
â€”
10/18â€”
4/5
2/2
0/2
0/4
2/3
8/16â€”
4/5
1/2
1/2
0/4
3/3
9/16â€”
8/10
0/4
0/1
0/4
â€”
8/19â€”
8/10
1/4
0/1
0/4
â€”
9/19*
Number of samples positive/number
t Relative to day of defervescence.tested.
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TABLE 4
Detection of dengue virus by mosquito inoculation (MI) and reverse transcriptaseâ€”polymerase chain reaction (RT-PCR) during the course of
illness*
virus detection and typing could be done in a single reaction
tube. We tried this procedure with our universal primers. We
obtained good results using virus stocks, but not from spec
imens of serum spiked with virus. We obtained rapid results
using a modified method that had been applied to dengue
virus with type-specific primers by Chungue and others,7
Chan and others,5 and Scab and rs'3 The universal prim
ers we used enable us to detect all four dengue serotypes in
a single reaction, thus reducing the cost and preparation time
of the test.
Based on the dengue virus nucleic acid sequences that
were available in the Genbank database, we designed uni
versal primers to amplify all four serotypes in a single re
action. These results show that RT-PCR using the primers
we selected can detect not only laboratory strains of dengue
virus, but also dengue viruses of all four serotypes in clinical
specimens with high sensitivity. These data suggest that the
sequences of these primers are well conserved among din
ical isolates of dengue virus.
The procedure we describe in this report can rapidly in
dicate whether or not an acutely febrile patient is infected
with dengue virus, which is critical for patient management.
In the preliminary experiment, we applied our method to
plasma specimens obtained on the day of presentation to the
outpatient clinic, no more than 72 hr after the onset of fever.
Dengue virus had been isolated from these specimens by
mosquito inoculation. We could detect dengue RNA in 38
of these 39 samples. The only sample that was negative by
PCR but positive by mosquito inoculation was obtained on
the lastday of fever.In the subsequentstudydoneon serial
plasma specimens obtained from children with acute febrile
illness, RT-PCR detected dengue virus in 34.2% of the sam
ples, while mosquito inoculation detected dengue virus in
29.9%. Compared with mosquito inoculation, the overall
sensitivity of the RT-PCR is 91.4% (32 of 35; 95% confi
dence interval [CI] 82.2â€”100%). For the samples obtained
at the time of clinical presentation, which are the most im
portant for clinical use, this method showed a sensitivity of
95.0% (19 of 20; 95% CI 85.5â€”100%).
All first day samples and 15 of the 17 later specimens that
were positive by both RT-PCR and mosquito inoculation
showed a strong, distinctive band, while the two false-pos
itive RT-PCR specimens were seen as weak bands and were
negative on repeat testing. Samples obtained later in the
course of acute dengue infection that were positive by
RT-PCR but negative by mosquito inoculation showed weak
bands, and five of six such samples were RT-PCR negative
on repeat testing. This result agrees with the observations
made by Gubler and others27 and Chan and others5 that sam
ples for either virus isolation or RT-PCR should ideally be
obtained in early phase of illness. These findings may reflect
a low virus titer in the plasma in the later stages of illness.
Gubler and others reported the presence of dengue virus at
low titer in patient serum as late as 12 days after the onset
of illness using the mosquito inoculation technique.27
The RT-PCR method we used had a specificity of 95.4%.
It is difficult to compare this result with other published
methods since none of the earlier reports on dengue RT-PCR
analyzed a large number of samples from patients with sus
pected dengue virus infection with complete serologic tests
as negative controls. A possibility that cannot be overlooked
is carry-over contamination; however, we exercised precau
tions to prevent carry-over contamination, such as the use
of several samples without RNA as controls in each run,
physical separation of pre- and post-PCR manipulations, and
the use of aerosol-barrier pipettes.
Several investigators have reported single-step RT-PCR
methods for detecting dengue iru69' â€˜â€˜@by using different
sources of RT and DNA polymerase. We tried several meth
ods using RT-AMV (Promega) and Tth DNA polymerase
(Promega), using rTth DNA polymerase (Perkin Elmer, Fos
ter City, CA), and the Access RT-PCRÂ® system (Promega)
containing RT-AMV and Thermus fiavus (Tfl) DNA poly
merase. We found the first two methods to be less sensitive
than our method. Chang and others6 and Lanciotti and oth
ers9 improved the sensitivity of their single-step RT-PCR by
ELISA or nested PCR, respectively. Since our objective is
to learn whether or not a patient is having dengue viremia
on the same day, we chose to continue using the conven
tional two-step RT-PCR and staining of DNA bands in aga
rose gels with ethidium bromide. Recently, we found that
the Access RT-PCRÂ® system gave a comparable sensitivity
with our method for detecting viral RNA in serum spiked
with dengue virus.
It is often difficult to clinically identify children with den
gue until defervescence. This rapid diagnostic assay, al
though not superior to the mosquito inoculation technique in
sensitivity, should be helpful in the rapid identification of
patients with dengue in the outpatient setting early in the
course of disease and useful in the early management of
children with the disease.
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